Effect of systemic monosodium L-glutamate on muscarinic cholinergic receptors in selected rat brain regions during development

[3H]quinuclidinyl benzilate ([3H]QNB) binding to muscarine acetylcholine receptors (mAchR) was measured in cerebral cortex and caudate nucleus of rats at the ages of 7, 14, and 21 days, which had received a subconvulsive intraperitoneal dose of monosodium L-glutamate (MSG) (4 mg/g) on postnatal days...

Full description

Saved in:
Bibliographic Details
Published inArchives of medical research Vol. 25; no. 3; p. 341
Main Authors Beas-Zárate, C, Schliebs, R, Ortuño-Sahagún, D, Morales-Villagrán, A, Feria-Velasco, A
Format Journal Article
LanguageEnglish
Published United States 1994
Subjects
Animals
Brain - drug effects
Brain - growth & development
Rats
Rats, Wistar
Receptors, Muscarinic - drug effects
Sodium Glutamate - pharmacology
Online AccessGet more information

Cover

More Information
Summary:[3H]quinuclidinyl benzilate ([3H]QNB) binding to muscarine acetylcholine receptors (mAchR) was measured in cerebral cortex and caudate nucleus of rats at the ages of 7, 14, and 21 days, which had received a subconvulsive intraperitoneal dose of monosodium L-glutamate (MSG) (4 mg/g) on postnatal days 1, 3, 5 and 7. MSG treatment determined an increase of mAchR density in cerebral cortex. This was 8, 15 and 25% at days 7, 14 and 21, respectively. In caudate nucleus, a significant increase of mAchR density was detected at day 7 (240%). However, on postnatal day 14, mAchR binding in caudate nucleus of MSG-treated rats was only 47% higher, while at 21 days, no changes in mAchR binding were found. When MSG was injected to adult rats, no changes in brain mAchR density were detected. Data suggest that early administration of MSG affects the development of mAchR in cerebral cortex and caudate nucleus, whereas the adult brain cortical cholinergic transmission is not sensitive to parenterally administered MSG.
ISSN:0188-4409